Fairvalue-Calculator Fairvalue-Calculator
EN DE

Level Biotechnology Inc (3118) Fair Value & Analysis

Healthcare · TW · Market cap 1.0B TWD

Price31.55 TWD
Fair Value32.95 TWD
Upside+4.4%
Quality95/100
Evidence: High Range 25.25 TWD – 45.93 TWD

Fair value as of: Jun 24, 2026

Analysis

Level Biotechnology Inc (3118) currently trades at 31.55 TWD, while our model-based Fair Value estimate is 32.95 TWD — implying the stock looks roughly 4.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. The company markets and distributes biomedical precision equipment. It also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Level Biotechnology Inc (3118) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 32.95 TWD versus a price of 31.55 TWD — about +4% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 3118?
Our 21-model fair value for Level Biotechnology Inc is 32.95 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 31.55 TWD.
What is the quality score of 3118?
Level Biotechnology Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.